{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:39:08Z","timestamp":1790753948514,"version":"4.1.0"},"reference-count":37,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"unspecified","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031951","name":"Sciensano","doi-asserted-by":"crossref","award":["grant number [OZ8478]"],"award-info":[{"award-number":["grant number [OZ8478]"]}],"id":[{"id":"10.13039\/100031951","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,1,12]]},"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>National SARS-CoV-2 seroprevalence data provide essential information about population exposure to the virus and help predict the future course of the epidemic. Early cohort studies have suggested declines in levels of antibodies in individuals associated with, for example, illness severity, age and comorbidities. This protocol focuses on the seroprevalence among primary healthcare providers (PHCPs) in Belgium. PHCPs manage the vast majority of (COVID-19) patients and therefore play an essential role in the efficient organisation of healthcare. Currently, evidence is lacking on (1) how many PHCPs get infected with SARS-CoV-2 in Belgium, (2) the rate at which this happens, (3) their clinical spectrum, (4) their risk factors, (5) the effectiveness of the measures to prevent infection and (6) the accuracy of the serology-based point-of-care test (POCT) in a primary care setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This study will be set up as a prospective cohort study. General practitioners (GPs) and other PHCPs (working in a GP practice) will be recruited via professional networks and professional media outlets to register online to participate. Registered GPs and other PHCPs will be asked at each testing point (n=9) to perform a capillary blood sample antibody POCT targeting IgM and IgG against the receptor-binding domain of SARS-CoV-2 and complete an online questionnaire. The primary outcomes are the prevalence and incidence of antibodies against SARS-CoV-2 in PHCPs during a 12-month follow-up period. Secondary outcomes include the longevity of antibodies against SARS-CoV-2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval has been granted by the ethics committee of the University Hospital of Antwerp\/University of Antwerp (Belgian registration number: 3002020000237). Alongside journal publications, dissemination activities include the publication of monthly reports to be shared with the participants and the general population through the publicly available website of the Belgian health authorities (Sciensano).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04779424\">NCT04779424<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-054688","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T02:58:13Z","timestamp":1643684293000},"page":"e054688","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol"],"prefix":"10.1136","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct04779424","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7957-1177","authenticated-orcid":false,"given":"Niels","family":"Adriaenssens","sequence":"first","affiliation":[{"name":"Department of Family Medicine and Population Health (FAMPOP), University of Antwerp, Antwerpen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Scholtes","sequence":"additional","affiliation":[{"name":"D\u00e9partement des Sciences Cliniques, University of Liege, Liege, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4217-2869","authenticated-orcid":false,"given":"Robin","family":"Bruyndonckx","sequence":"additional","affiliation":[{"name":"Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-BioStat), Data Science Institute, Hasselt University, Hasselt, Belgium"},{"name":"Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerpen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7166-7211","authenticated-orcid":false,"given":"Jan Y","family":"Verbakel","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium"},{"name":"Nuffield Department of Primary Care Health Sciences, Oxford University, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"De Sutter","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care, Ghent University, Gent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1097-4987","authenticated-orcid":false,"given":"Stefan","family":"Heytens","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care, Ghent University, Gent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Van den Bruel","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Desombere","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases in Humans, Sciensano, Brussel, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Van Damme","sequence":"additional","affiliation":[{"name":"Centre for the Evaluation of Vaccination, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerpen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Goossens","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerpen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La\u00ebtitia","family":"Buret","sequence":"additional","affiliation":[{"name":"D\u00e9partement des Sciences Cliniques, University of Liege, Liege, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els","family":"Duysburgh","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Sciensano, Brussel, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1238-8052","authenticated-orcid":false,"given":"Samuel","family":"Coenen","sequence":"additional","affiliation":[{"name":"Department of Family Medicine and Population Health (FAMPOP), University of Antwerp, Antwerpen, Belgium"},{"name":"Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerpen, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"2025121509525612000_12.1.e054688.1","unstructured":"WHO coronavirus (COVID-19) Dashboard. Available: https:\/\/covid19.who.int [Accessed 17 May 2021]."},{"key":"2025121509525612000_12.1.e054688.2","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1056\/NEJMe2028079","article-title":"The power of antibody-based surveillance","volume":"383","author":"Alter","year":"2020","journal-title":"N Engl J Med"},{"key":"2025121509525612000_12.1.e054688.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1018-x"},{"key":"2025121509525612000_12.1.e054688.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026116G"},{"key":"2025121509525612000_12.1.e054688.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31483-5"},{"key":"2025121509525612000_12.1.e054688.6","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1001\/jama.2020.18796","article-title":"Change in antibodies to SARS-CoV-2 over 60 days among health care personnel in Nashville, Tennessee","volume":"324","author":"Patel","year":"2020","journal-title":"JAMA"},{"key":"2025121509525612000_12.1.e054688.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41591020-0965-6"},{"key":"2025121509525612000_12.1.e054688.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2025179pmid:32706954"},{"key":"2025121509525612000_12.1.e054688.9","doi-asserted-by":"publisher","DOI":"10.1093\/INFDIS\/JIAB255"},{"key":"2025121509525612000_12.1.e054688.10","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30943-9"},{"key":"2025121509525612000_12.1.e054688.11","unstructured":"Merckx J , Vermeulen M , Vandermeulen C . Prevalence and incidence of antibodies against SARS-CoV-2 in children and school staff measured for one year in Belgium: a sero-epidemiological prospective cohort study. Available: https:\/\/www.sciensano.be\/nl\/biblio\/prevalence-and-incidence-antibodies-against-sars-cov-2-children-and-school-staff-measured-one-year [Accessed 17 May 2021]."},{"key":"2025121509525612000_12.1.e054688.12","unstructured":"Mortgat L , Arien K , Barbezange C . SARS-CoV-2 prevalence, seroprevalence and seroconversion among healthcare workers in Belgium during the 2020 Covid-19 outbreak: study protocol. Available: https:\/\/www.sciensano.be\/nl\/biblio\/sars-cov-2-prevalence-seroprevalence-and-seroconversion-among-healthcare-workers-belgium-during-2020 [Accessed 17 May 2021]."},{"key":"2025121509525612000_12.1.e054688.13","unstructured":"De Sutter A , Heytens S , Duysburgh E . SARS-CoV-2 seroprevalence among nursing home staff and residents in Belgium: protocol. Available: https:\/\/www.sciensano.be\/nl\/biblio\/sars-cov-2-seroprevalence-among-nursing-home-staff-and-residents-belgium-protocol [Accessed 17 May 2021]."},{"key":"2025121509525612000_12.1.e054688.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90634-3"},{"key":"2025121509525612000_12.1.e054688.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03470160100040"},{"key":"2025121509525612000_12.1.e054688.16","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268821000297","article-title":"Analysing how changes in the health status of healthcare workers affects epidemic outcomes","volume":"149","author":"Phadke","year":"2021","journal-title":"Epidemiol Infect"},{"key":"2025121509525612000_12.1.e054688.17","unstructured":"Federale Overheidsdienst Volksgezondheid Veiligheid van de Voedselketen en Leefmilieu . Jaarstatistieken met betrekking tot de beoefenaars van gezondheidszorgberoepen in Belgi\u00eb, 2020. Available: https:\/\/overlegorganen.gezondheid.belgie.be\/sites\/default\/files\/documents\/statan_2019_-_nl.pdf [Accessed 17 May 2021]."},{"key":"2025121509525612000_12.1.e054688.18","unstructured":"Federazione Nazionale degli Ordini dei Medici Chirurghi e degli Odontoiatri . Elenco dei Medici caduti nel corso dell\u2019epidemia di Covid-19. Available: https:\/\/portale.fnomceo.it\/elenco-dei-medici-caduti-nel-corso-dellepidemia-di-covid-19\/ [Accessed 17 May 2021]."},{"key":"2025121509525612000_12.1.e054688.19","doi-asserted-by":"crossref","first-page":"104897","DOI":"10.1016\/j.jcv.2021.104897","article-title":"Performance of five rapid serological tests in mild-diseased subjects using finger prick blood for exposure assessment to SARS-CoV-2","volume":"142","author":"Triest","year":"2021","journal-title":"J Clin Virol"},{"key":"2025121509525612000_12.1.e054688.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18450-4"},{"key":"2025121509525612000_12.1.e054688.21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4236\/oji.2020.102003","article-title":"Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies","volume":"10","author":"Gonzalez","year":"2020","journal-title":"Open J Immunol"},{"key":"2025121509525612000_12.1.e054688.22","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64206","article-title":"Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys","volume":"10","author":"Larremore","year":"2021","journal-title":"Elife"},{"key":"2025121509525612000_12.1.e054688.23","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/clinchem\/hvaa131","article-title":"Clinical performance of the Elecsys Electrochemiluminescent immunoassay for the detection of SARS-CoV-2 total antibodies","volume":"66","author":"Favresse","year":"2020","journal-title":"Clin Chem"},{"key":"2025121509525612000_12.1.e054688.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.05.049"},{"key":"2025121509525612000_12.1.e054688.25","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1515\/cclm-2020-0594","article-title":"Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody","volume":"58","author":"Tr\u00e9-Hardy","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"2025121509525612000_12.1.e054688.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104480"},{"key":"2025121509525612000_12.1.e054688.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(96)00236-3"},{"key":"2025121509525612000_12.1.e054688.28","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4"},{"key":"2025121509525612000_12.1.e054688.29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m441"},{"key":"2025121509525612000_12.1.e054688.30","doi-asserted-by":"publisher","DOI":"10.1177\/0962280210395740"},{"key":"2025121509525612000_12.1.e054688.31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i402"},{"key":"2025121509525612000_12.1.e054688.32","doi-asserted-by":"publisher","DOI":"10.2307\/2530820"},{"key":"2025121509525612000_12.1.e054688.33","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/73.1.13"},{"key":"2025121509525612000_12.1.e054688.34","doi-asserted-by":"crossref","unstructured":"Hosmer DW , Lemeshow S . Applied logistic regression. New York: John Wiley & Sons, 1989.","DOI":"10.2307\/2531779"},{"key":"2025121509525612000_12.1.e054688.35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/fampra\/cmab094","article-title":"Prospective SARS-CoV-2 cohort study among primary health care providers during the second COVID-19 wave in Flanders, Belgium","volume":"39","author":"Mari\u00ebn","year":"2022","journal-title":"Fam Pract"},{"key":"2025121509525612000_12.1.e054688.36","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-017-0310-z","article-title":"Participant retention practices in longitudinal clinical research studies with high retention rates","volume":"17","author":"Abshire","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"2025121509525612000_12.1.e054688.37","unstructured":"Sciensano . Dashboard. Available: https:\/\/epistat.wiv-isp.be\/covid\/covid-19.html [Accessed 17 May 2021]."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-054688","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T17:53:04Z","timestamp":1765821184000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-054688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1,31]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1136\/bmjopen-2021-054688"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-054688","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.06.18.21259139","asserted-by":"object"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}